AG-221,
enasidenib,
Enasidenib,
1446502-11-9,
AG-221,
Enasidenib mesylate,
UNII-3T1SS4E7AG,
CC-90007 Free Base,
IDHIFA,
3T1SS4E7AG,
AG221,
CC-90007,
2-Methyl-1-(4-(6-(trifluoromethyl)pyridin-2-yl)-6-(2-(trifluoromethyl)pyridin-4-ylamino)-1,3,5-triazin-2-ylamino)propan-2-ol,
2-methyl-1-((4-(6-(trifluoromethyl)pyridin-2-yl)-6-((2-(trifluoromethyl)pyridin-4-yl)amino)-1,3,5-triazin-2-yl)amino)propan-2-ol,
2-Propanol, 2-methyl-1-((4-(6-(trifluoromethyl)-2-pyridinyl)-6-((2-(trifluoromethyl)-4-pyridinyl)amino)-1,3,5-triazin-2-yl)amino)-,
2-Methyl-1-[(4-[6-(Trifluoromethyl)pyridin-2-Yl]-6-{[2-(Trifluoromethyl)pyridin-4-Yl]amino}-1,3,5-Triazin-2-Yl)amino]propan-2-Ol,
2-methyl-1-[[4-[6-(trifluoromethyl)pyridin-2-yl]-6-[[2-(trifluoromethyl)pyridin-4-yl]amino]-1,3,5-triazin-2-yl]amino]propan-2-ol,
Enasidenib [INN],
2-Propanol, 2-methyl-1-[[4-[6-(trifluoromethyl)-2-pyridinyl]-6-[[2-(trifluoromethyl)-4-pyridinyl]amino]-1,3,5-triazin-2-yl]amino]-,
ag-221-enasidenib,
AG-221(Enasidenib),
AG-221; Enasidenib,
Enasidenib (USAN/INN),
Enasidenib [USAN:INN],
AG-221 (Enasidenib),
Enasidenib (AG-221),
GTPL8960,
CHEMBL3989908,
SCHEMBL15102202,
EX-A654,
BCP16041,
KS-000006AW,
AG 221,
MFCD29472245,
s8205,
AKOS026750439,
ZINC222731806,
CC90007,
CS-5017,
DB13874,
SB19193,
NCGC00479249-03,
NCGC00479249-05,
AK431837,
CC 90007,
HY-18690,
FT-0700204,
D10901,
J-690181,
69Q,
AG-221 mesylate,
WZB117,
A15808,
1223397-11-2,
4-[3-(4-hydroxybutyl)-4,4-dimethyl-2,5-dioxo-1-imidazolidinyl]-2-(trifluoromethyl)benzonitrile,